|
|
 About Us |
|
Development of novel human vaccines and therapeutic agents against infectious and autoimmune diseases as well as cancer in laboratories at the National Research Council (NRC) of Canada has resulted in technologies and expertise that relate to biomedical applications of carbohydrates.
Sussex Research is a privately-held chemistry focused company leading in the design and manufacture of Advanced Glycosylation products and synthesis solutions for biopharmaceutical, diagnostic and research applications. The company specializes in carbohydrate and glycosylation chemistry, and is developing proprietary strategies and products designed to (1) overcome problems associated with the synthesis of carbohydrate-based molecules and glycoconjugate vaccines, (2) enhance the properties of therapeutics and (3) improve targeting, transport, solubility and stability of synthetic therapeutic molecules such as small molecules, peptides and oligonucleotides. |
|
| Contact Us |
|
Add: |
100 Sussex Drive, Suite 1120G Ottawa, Ontario Canada |
|
Contact: |
K. Brady Clark, Ph.D. |
|
Tel: |
+1 613 993-4402 |
|
Fax: |
+1 613 998-3399 |
|
Web Site: |
http://www.sussex-research.com |
|
Contact us | Help
